E. B. Silberstein: Teletherapy and radiopharmaceutical therapy of painful bone metastases. In: Seminars in nuclear medicine Band 35, Nummer 2, April 2005, S. 152–158, ISSN0001-2998. doi:10.1053/j.semnuclmed.2004.11.006. PMID 15765378. (Review).
D. A. Loblaw, J. S. Wu, P. Kirkbride, T. Panzarella, K. Smith, J. Aslanidis, P. Warde: Pain flare in patients with bone metastases after palliative radiotherapy–a nested randomized control trial. In: Supportive care in cancer Band 15, Nummer 4, April 2007, S. 451–455, ISSN0941-4355. doi:10.1007/s00520-006-0166-y. PMID 17093912.
J. C. Sisson, Y. K. Dewaraja, E. J. Wizauer, T. J. Giordano, A. M. Avram: Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine. In: Thyroid Band 19, Nummer 3, März 2009, S. 297–303, ISSN1557-9077. doi:10.1089/thy.2008.0426. PMID 19207003. PMC 2727798 (freier Volltext).
S. Iwano, K. Kato, T. Nihashi, S. Ito, Y. Tachi, S. Naganawa: Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer. In: Annals of nuclear medicine Band 23, Nummer 9, November 2009, S. 777–782, ISSN1864-6433. doi:10.1007/s12149-009-0303-z. PMID 19787312.
S. Nilsson, L. Franzén, C. Parker, C. Tyrrell, R. Blom, J. Tennvall, B. Lennernäs, U. Petersson, D. C. Johannessen, M. Sokal, K. Pigott, J. Yachnin, M. Garkavij, P. Strang, J. Harmenberg, B. Bolstad, O. S. Bruland: Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. In: The Lancet Oncology Band 8, Nummer 7, Juli 2007, S. 587–594, ISSN1470-2045. doi:10.1016/S1470-2045(07)70147-X. PMID 17544845.
M. D. Shelley, M. D. Mason: Radium-223 for men with hormone-refractory prostate cancer and bone metastases. In: The lancet oncology Band 8, Nummer 7, Juli 2007, S. 564–565, ISSN1470-2045. doi:10.1016/S1470-2045(07)70180-8. PMID 17613416.
R. G. Robinson, D. F. Preston, M. Schiefelbein, K. G. Baxter: Strontium 89 therapy for the palliation of pain due to osseous metastases. In: JAMA Band 274, Nummer 5, August 1995, S. 420–424, ISSN0098-7484. PMID 7542352. (Review).
S. K. Shukla, G. S. Limouris, R. Cusumano, A. Acconcia, C. Cipriani, G. Atzei, G. Argirò, S. Boemi: Advanced prostate cancer diagnosis and therapy with gallium-67 and yttrium-90, respectively. In: Anticancer Research Band 17, Nummer 3B, 1997 May-Jun, S. 1731–1734, ISSN0250-7005. PMID 9179226.
E. B. Silberstein: Teletherapy and radiopharmaceutical therapy of painful bone metastases. In: Seminars in nuclear medicine Band 35, Nummer 2, April 2005, S. 152–158, ISSN0001-2998. doi:10.1053/j.semnuclmed.2004.11.006. PMID 15765378. (Review).
D. A. Loblaw, J. S. Wu, P. Kirkbride, T. Panzarella, K. Smith, J. Aslanidis, P. Warde: Pain flare in patients with bone metastases after palliative radiotherapy–a nested randomized control trial. In: Supportive care in cancer Band 15, Nummer 4, April 2007, S. 451–455, ISSN0941-4355. doi:10.1007/s00520-006-0166-y. PMID 17093912.
J. C. Sisson, Y. K. Dewaraja, E. J. Wizauer, T. J. Giordano, A. M. Avram: Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine. In: Thyroid Band 19, Nummer 3, März 2009, S. 297–303, ISSN1557-9077. doi:10.1089/thy.2008.0426. PMID 19207003. PMC 2727798 (freier Volltext).
S. Iwano, K. Kato, T. Nihashi, S. Ito, Y. Tachi, S. Naganawa: Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer. In: Annals of nuclear medicine Band 23, Nummer 9, November 2009, S. 777–782, ISSN1864-6433. doi:10.1007/s12149-009-0303-z. PMID 19787312.
A. N. Serafini: Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease. In: International journal of radiation oncology, biology, physics Band 30, Nummer 5, Dezember 1994, S. 1187–1194, ISSN0360-3016. PMID 7525518. (Review).
M. A. Ritter, J. E. Cleaver, C. A. Tobias: High-LET radiations induce a large proportion of non-rejoining DNA breaks. In: Nature Band 266, Nummer 5603, April 1977, S. 653–655, ISSN0028-0836. PMID 859634.
H. R. Withers, K. Mason, B. O. Reid, N. Dubravsky, H. T. Barkley, B. W. Brown, J. B. Smathers: Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. In: Cancer Band 34, Nummer 1, Juli 1974, S. 39–47, ISSN0008-543X. PMID 4834165.
S. Nilsson, L. Franzén, C. Parker, C. Tyrrell, R. Blom, J. Tennvall, B. Lennernäs, U. Petersson, D. C. Johannessen, M. Sokal, K. Pigott, J. Yachnin, M. Garkavij, P. Strang, J. Harmenberg, B. Bolstad, O. S. Bruland: Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. In: The Lancet Oncology Band 8, Nummer 7, Juli 2007, S. 587–594, ISSN1470-2045. doi:10.1016/S1470-2045(07)70147-X. PMID 17544845.
R. L. Carter: Patterns and mechanisms of bone metastases. In: Journal of the Royal Society of Medicine Band 78 Suppl 9, 1985, S. 2–6, ISSN0141-0768. PMID 4045915. PMC 1289525 (freier Volltext).
M. D. Shelley, M. D. Mason: Radium-223 for men with hormone-refractory prostate cancer and bone metastases. In: The lancet oncology Band 8, Nummer 7, Juli 2007, S. 564–565, ISSN1470-2045. doi:10.1016/S1470-2045(07)70180-8. PMID 17613416.
R. G. Robinson, D. F. Preston, M. Schiefelbein, K. G. Baxter: Strontium 89 therapy for the palliation of pain due to osseous metastases. In: JAMA Band 274, Nummer 5, August 1995, S. 420–424, ISSN0098-7484. PMID 7542352. (Review).
S. K. Shukla, G. S. Limouris, R. Cusumano, A. Acconcia, C. Cipriani, G. Atzei, G. Argirò, S. Boemi: Advanced prostate cancer diagnosis and therapy with gallium-67 and yttrium-90, respectively. In: Anticancer Research Band 17, Nummer 3B, 1997 May-Jun, S. 1731–1734, ISSN0250-7005. PMID 9179226.
E. B. Silberstein: Teletherapy and radiopharmaceutical therapy of painful bone metastases. In: Seminars in nuclear medicine Band 35, Nummer 2, April 2005, S. 152–158, ISSN0001-2998. doi:10.1053/j.semnuclmed.2004.11.006. PMID 15765378. (Review).
D. A. Loblaw, J. S. Wu, P. Kirkbride, T. Panzarella, K. Smith, J. Aslanidis, P. Warde: Pain flare in patients with bone metastases after palliative radiotherapy–a nested randomized control trial. In: Supportive care in cancer Band 15, Nummer 4, April 2007, S. 451–455, ISSN0941-4355. doi:10.1007/s00520-006-0166-y. PMID 17093912.
J. C. Sisson, Y. K. Dewaraja, E. J. Wizauer, T. J. Giordano, A. M. Avram: Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine. In: Thyroid Band 19, Nummer 3, März 2009, S. 297–303, ISSN1557-9077. doi:10.1089/thy.2008.0426. PMID 19207003. PMC 2727798 (freier Volltext).
S. Iwano, K. Kato, T. Nihashi, S. Ito, Y. Tachi, S. Naganawa: Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer. In: Annals of nuclear medicine Band 23, Nummer 9, November 2009, S. 777–782, ISSN1864-6433. doi:10.1007/s12149-009-0303-z. PMID 19787312.
A. N. Serafini: Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease. In: International journal of radiation oncology, biology, physics Band 30, Nummer 5, Dezember 1994, S. 1187–1194, ISSN0360-3016. PMID 7525518. (Review).
M. A. Ritter, J. E. Cleaver, C. A. Tobias: High-LET radiations induce a large proportion of non-rejoining DNA breaks. In: Nature Band 266, Nummer 5603, April 1977, S. 653–655, ISSN0028-0836. PMID 859634.
H. R. Withers, K. Mason, B. O. Reid, N. Dubravsky, H. T. Barkley, B. W. Brown, J. B. Smathers: Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. In: Cancer Band 34, Nummer 1, Juli 1974, S. 39–47, ISSN0008-543X. PMID 4834165.
S. Nilsson, L. Franzén, C. Parker, C. Tyrrell, R. Blom, J. Tennvall, B. Lennernäs, U. Petersson, D. C. Johannessen, M. Sokal, K. Pigott, J. Yachnin, M. Garkavij, P. Strang, J. Harmenberg, B. Bolstad, O. S. Bruland: Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. In: The Lancet Oncology Band 8, Nummer 7, Juli 2007, S. 587–594, ISSN1470-2045. doi:10.1016/S1470-2045(07)70147-X. PMID 17544845.
R. L. Carter: Patterns and mechanisms of bone metastases. In: Journal of the Royal Society of Medicine Band 78 Suppl 9, 1985, S. 2–6, ISSN0141-0768. PMID 4045915. PMC 1289525 (freier Volltext).
M. D. Shelley, M. D. Mason: Radium-223 for men with hormone-refractory prostate cancer and bone metastases. In: The lancet oncology Band 8, Nummer 7, Juli 2007, S. 564–565, ISSN1470-2045. doi:10.1016/S1470-2045(07)70180-8. PMID 17613416.
